THC Farmaceuticals, Inc. (CBDG)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 635.53 Thousand | 317.88 Thousand | -11.76 Thousand | -2206.00 | -134.23 Thousand | -9150.00 |
| Net Income | -14.97 Thousand | 426.9 Thousand | -8420.00 | -60.44 Thousand | -498.56 Thousand | -15.24 Thousand |
| Depreciation & Amortization | 4952.00 | 3808.00 | 952.00 | 952.00 | 953.00 | 953.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 650.51 Thousand | -112.82 Thousand | 4093.00 | 29.54 Thousand | 22.9 Thousand | 5142.00 |
| Other non-cash items | -4952.00 | - | -4248.00 | 18.1 Thousand | 334.47 Thousand | -3236.00 |
| Investing Cash Flow | -635.53 Thousand | 19.15 Thousand | - | - | - | 30 Thousand |
| Investments in PPE | 3.00 | 5.00 | 1.00 | - | - | - |
| Acquisitions | -14.02 Thousand | -844.00 | - | - | - | 30 Thousand |
| Investment purchases | -621.51 Thousand | - | - | - | - | - |
| Sales/Maturities of investments | - | 645 Thousand | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | -354.16 Thousand | 28.01 Thousand | 2244.00 | 105.07 Thousand | 9150.00 |
| Debt repayment | - | -354.16 Thousand | -1000.00 | -1000.00 | - | -9150.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | 29.01 Thousand | 1244.00 | 105.07 Thousand | - |
| Accounts receivables | 621.51 Thousand | - | -2234.00 | -7674.00 | - | - |
| Accounts payables | - | -30.02 Thousand | - | 19.21 Thousand | 7902.00 | 5142.00 |
| Inventory | - | - | - | - | - | - |
| Other working capital | 29 Thousand | -82.8 Thousand | 6327.00 | 18 Thousand | 15 Thousand | - |
| Cash at beginning of period | 1714.00 | 18.83 Thousand | 2588.00 | 2550.00 | 31.71 Thousand | 1714.00 |
| Cash at end of period | 1714.00 | 1714.00 | 18.83 Thousand | 2588.00 | 2550.00 | 31.71 Thousand |
| Capital Expenditure | 3.00 | 5.00 | 1.00 | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | -17.12 Thousand | 16.25 Thousand | 38.00 | -29.16 Thousand | 30 Thousand |
| Free Cash Flow | 635.54 Thousand | 317.89 Thousand | -11.76 Thousand | -2206.00 | -134.23 Thousand | -9150.00 |
| Breakdown | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 FY | 2020 FY | 2020 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3163.00 | -5637.00 | -844.00 | -8420.00 | -60.44 Thousand | 57.77 Thousand |
| Depreciation & Amortization | 952.00 | 952.00 | 952.00 | 952.00 | 952.00 | 238.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -851.00 | 719.00 | -6022.00 | 4093.00 | 29.54 Thousand | -3067.00 |
| Other non-cash items | 484.00 | 1903.00 | 1280.00 | -4248.00 | 18.1 Thousand | -63.91 Thousand |
| Investing Cash Flow | -3162.00 | -5637.00 | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | -3162.00 | -5637.00 | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 3524.00 | 9135.00 | -844.00 | 28.01 Thousand | 2244.00 | 13.32 Thousand |
| Debt repayment | -4368.00 | -8291.00 | - | -1000.00 | -1000.00 | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -844.00 | 844.00 | -844.00 | 29.01 Thousand | 1244.00 | 13.32 Thousand |
| Accounts receivables | - | - | - | -2234.00 | -7674.00 | -100.00 |
| Accounts payables | - | - | - | - | 19.21 Thousand | -2967.00 |
| Inventory | - | - | - | - | - | - |
| Other working capital | -851.00 | 719.00 | -6022.00 | 6327.00 | 18 Thousand | - |
| Cash at beginning of period | 10.14 Thousand | 11.45 Thousand | 3363.00 | 2588.00 | 2550.00 | 2550.00 |
| Cash at end of period | 6869.00 | 10.14 Thousand | 11.45 Thousand | 18.83 Thousand | 2588.00 | 3363.00 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 844.00 | - | - | - | - | - |
| Net cash flow / Change in cash | -3276.00 | -1313.00 | 8095.00 | 16.25 Thousand | 38.00 | 813.00 |
| Free Cash Flow | -4482.00 | -3967.00 | -6538.00 | -11.76 Thousand | -2206.00 | -12.51 Thousand |
AVBP
ARRRF
STG
ACRFF
6028
WPB